ALAVITA PHARMACEUTICALS INC has a total of 21 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and biotechnology are DIPEXIUM PHARMACEUTICALS INC, BAJER EHNIMEHL KHEL S GMBKH and FIDELINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 2 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Basic materials chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Preservation of human bodies | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Allison Anthony | 20 |
#2 | Zehnder James L | 1 |
#3 | Allison Anthony Clifford | 1 |
#4 | Ringold Gordon | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011069090A1 | Inhibition of the activation of coagulation factor xii by ligands of phosphatidylserine | |
US2009291086A1 | Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia | |
US2008069823A1 | Attenuation of reperfusion injury | |
US2007054855A1 | Modified annexin compositions and methods of using same | |
US2007015705A1 | Modified annexin compositions and methods of using same | |
AU2005221195A1 | Modified annexin proteins and methods for preventing thrombosis |